Statistics
Publications
28
Citations
1.5K
H-Index
18
Active since
2005
Peter Gennemark is an author at AstraZeneca (Sweden) specializing in pharmacology, pharmacy, and medicine.
Publications per year
2005–2024
28
28
Integrative model of the response of yeast to osmotic shock
Edda Klipp, Bodil Nordlander, Roland Krüger et al. · Nature Biotechnology · 2005 · 454 citations · Full text
Life Sciences, Biology, Microbiology +14
Models from experiments: combinatorial drug perturbations of cancer cells
Sven Nelander, Weiqing Wang, Qing‐Bai She et al. · Molecular Systems Biology · 2008 · 189 citations · Full text
Medicine, Oncology, Pharmacology +16
An oral antisense oligonucleotide for PCSK9 inhibition
Peter Gennemark, Katrin Walter, Niclas Clemmensen et al. · Science Translational Medicine · 2021 · 121 citations
Structural and functional characterization of a specific antidote for ticagrelor
Andrew Buchanan, Philip M. Newton, S. KENNETH PEHRSSON et al. · Blood · 2015 · 91 citations · Full text
1–5 of 28